EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Variants of the Receptor Activator Nuclear of κB Ligand Gene Increase the Risk of Rheumatoid Arthritis in a Mexican Mestizo Population: A Case–Control Study

Nava-Valdivia Cesar Arturo iD, Gamez-Nava Jorge Ivan, Contreras-Haro Betsabe, Perez-Guerrero Edsaul Emilio iD, Esparza-Guerrero Yussef iD, Rodriguez-Jimenez Norma Alejandra, Gonzalez-Heredia Tonatiuh iD, Villagomez-Vega Alejandra iD, Nuño-Arana Ismael iD, Totsuka-Sutto Sylvia Elena, Ponce-Guarneros Juan Manuel iD, Jacobo-Cuevas Heriberto und 3 weitere

Genes · 2024

DOI: 10.3390/genes15070907 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Nava-Valdivia Cesar Arturo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Microbiología y Patología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Polymorphism, Single Nucleotide, RANK Ligand, Genetic Predisposition to Disease. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Receptor Activator Nuclear of κB Ligand (RANKL) plays an important function in immune responses, activating osteoclast cells and unchanged bone resorption, which in turn leads to bone erosion and inflammation. Genetic variants in the promoter region of the RANKL gene could lead to a higher risk of rheumatoid arthritis (RA).

Objective

To assess the association of rs9533155 (-693C>G) and rs9533156 (-643T>C) genetic variants with RA risk.

Methods

A case–control study was carried out. A total of 94 patients with RA (RA group) and 134 subjects without any rheumatologic disease (control group) were included. Genetic DNA was extracted from peripheral white blood cells (leukocytes). Genetic variant rs9533155 (-693C>G) was screened by an approach based on Polymerase Chain Reaction–Restriction Fragment Length Polymorphism (PCR-RFLP), while rs9533156 (-643T>C) was screened using quantitative polymerase chain reaction (qPCR) with TaqMan probes. RANKL serum levels were measured by ELISA.

Results

For rs9533155 (-693C>G), the polymorphic homozygous genotype frequencies (CC) were higher in the RA group (p = 0.006). Individuals carrying the risk genotype presented higher levels of serum RANKL. Carriers of the polymorphic homozygous genotype in the dominant model (CC vs. CG + GG) had an increased risk of developing RA (OR: 1.8, 95% CI 1.04 to 3.1). No association between rs9533156 (-643T>C) and the haplotypes with RA risk was observed.

Conclusion

The rs9533155 (-693C>G) genetic variant exhibits a potential role in RA risk. The studied population had no association with the rs9533156 (-643T>C) genetic variant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidPolymorphism, Single NucleotideRANK LigandGenetic Predisposition to DiseaseHumansFemaleMaleMexicoMiddle AgedCase-Control StudiesAdultGene FrequencyAged

Stichwörter der Autor:innen

RANK ligandgenetic variantrheumatoid arthritis

Substanzen

RANK LigandTNFSF11 protein, human

Autor:innen und Institutionen

  • Departamento de Microbiología y Patología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
  • Programa de Doctorado en Farmacología, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
  • Instituto de Terapéutica Experimental y Clínica, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
  • Unidad de Investigación Biomédica 02, UMAE, Hospital de Especialidades, Centro Médico Nacional de Occidente, IMSS, Guadalajara 44349, Mexico.
  • Departamento de Ciencias Biomédicas, Centro Universitario de Tonalá, Universidad de Guadalajara, Guadalajara 45400, Mexico.
  • Instituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.

ORCID-Profile: Nava-Valdivia Cesar Arturo, Perez-Guerrero Edsaul Emilio, Esparza-Guerrero Yussef, Gonzalez-Heredia Tonatiuh, Villagomez-Vega Alejandra, Nuño-Arana Ismael, Ponce-Guarneros Juan Manuel, Gonzalez-Lopez Laura, Saldaña-Cruz Ana Miriam

Zitieren

APA

Arturo, N. C., Ivan, G. J., Betsabe, C. H., Emilio, P. E., Yussef, E. G., Alejandra, R. N., Tonatiuh, G. H., Alejandra, V. V., Ismael, N. A., Elena, T. S., Manuel, P. J., Heriberto, J. C., Gerardo, A. E., Laura, G. L., & Miriam, S. A. (2024). Genetic Variants of the Receptor Activator Nuclear of κB Ligand Gene Increase the Risk of Rheumatoid Arthritis in a Mexican Mestizo Population: A Case–Control Study. Genes. https://doi.org/10.3390/genes15070907

Vancouver

Arturo NC, Ivan GJ, Betsabe CH, Emilio PE, Yussef EG, Alejandra RN, et al. Genetic Variants of the Receptor Activator Nuclear of κB Ligand Gene Increase the Risk of Rheumatoid Arthritis in a Mexican Mestizo Population: A Case–Control Study. Genes. 2024. doi:10.3390/genes15070907

BibTeX
@article{Arturo2024,
  author = {Arturo, Nava-Valdivia Cesar and Ivan, Gamez-Nava Jorge and Betsabe, Contreras-Haro and Emilio, Perez-Guerrero Edsaul and Yussef, Esparza-Guerrero and Alejandra, Rodriguez-Jimenez Norma and Tonatiuh, Gonzalez-Heredia and Alejandra, Villagomez-Vega and Ismael, Nuño-Arana and Elena, Totsuka-Sutto Sylvia and Manuel, Ponce-Guarneros Juan and Heriberto, Jacobo-Cuevas and Gerardo, Alvarez-Ayala Efren and Laura, Gonzalez-Lopez and Miriam, Saldaña-Cruz Ana},
  title = {Genetic Variants of the Receptor Activator Nuclear of κB Ligand Gene Increase the Risk of Rheumatoid Arthritis in a Mexican Mestizo Population: A Case–Control Study},
  journal = {Genes},
  year = {2024},
  doi = {10.3390/genes15070907}
}
Kostenlos starten →